For example, in mice with low hepatic expression of PPARγ, rosiglitazone protects against lipid accumulation while in obese mice with elevated PPARγ, rosiglitazone exacerbates hepatic steatosis [28]. The gene discussed is PPARG; the disease is fatty liver disease.